Borderline ovarian tumors in Sweden 1960–2005: trends in incidence and age at diagnosis compared to ovarian cancer

I Skírnisdóttir, H Garmo, E Wilander… - International journal of …, 2008 - Wiley Online Library
The aim of the study was to investigate long‐term trends in the incidence of borderline
tumors and ovarian cancer in Sweden during 1960–2005, based on data from the …

Non-genital tract metastases to the ovaries presented as ovarian tumors in Sweden 1990–2003: occurrence, origin and survival compared to ovarian cancer

I Skírnisdóttir, H Garmo, L Holmberg - Gynecologic Oncology, 2007 - Elsevier
OBJECTIVE.: The aim of this register study was to determine occurrence of non-genital
ovarian metastasis detected by gynecologic surgery presented as ovarian neoplasm in …

A new prognostic model comprising p53, EGFR, and tumor grade in early stage epithelial ovarian carcinoma and avoiding the problem of inaccurate surgical staging

I Skírnisdóttir, T Seidal, B Sorbe - International Journal of Gynecologic …, 2004 - ijgc.bmj.com
Epithelial ovarian carcinoma rarely occurs because of a single event. Therefore, no single
biological tumor factor will give accurate prognostic information for all ovarian cancer …

Clinical and biological characteristics of clear cell carcinomas of the ovary in FIGO stages I-II

I Skírnisdóttir, T Seidal… - … journal of oncology, 2005 - spandidos-publications.com
Clear cell carcinoma of the ovary is considered to be a specific subtype among the epithelial
ovarian malignancies. To characterize clear cell carcinomas in early FIGO stages (I-II) with …

Prognostic impact of concomitant p53 and PTEN on outcome in early stage (FIGO I-II) epithelial ovarian cancer

I Skírnisdóttir, T Seidal - International Journal of Gynecologic Cancer, 2011 - ijgc.bmj.com
Introduction: The objective of the study was to evaluate the prognostic effect of p53, PTEN,
and concomitant p53 PTEN status on clinicopathologic features, recurrent disease, and …

Prognostic impact of p53, p27, and C-MYC on clinicopathological features and outcome in early-stage (FIGO I-II) epithelial ovarian cancer

IA Skírnisdóttir, B Sorbe, K Lindborg… - International Journal of …, 2011 - ijgc.bmj.com
Introduction: The objective of the study was to evaluate the prognostic effect of p53, p27, and
C-MYC on clinicopathological features, recurrent disease, and disease-free survival (DFS) …

Prognostic factors for surgical outcome and survival in 447 women treated for advanced (FIGO-stages III-IV) epithelial ovarian carcinoma

I Skírnisdóttir, B Sorbe - International journal of …, 2007 - spandidos-publications.com
The objectives of this population-based, retrospective study, was to find predictive factors for
surgical outcome and long-term survival in 447 patients with epithelial ovarian cancer in …

Body mass index as a prognostic factor in epithelial ovarian cancer and correlation with clinico-pathological factors

I Skírnisdóttir, B Sorbe - Acta obstetricia et gynecologica …, 2010 - Taylor & Francis
Objective. To find out if body mass index (BMI) was associated with clinico-pathological
features and prognosis in epithelial ovarian cancer (EOC). Design. Retrospective cohort …

The apoptosis regulators p53, bax and PUMA: Relationship and impact on outcome in early stage (FIGO I-II) ovarian carcinoma after post-surgical taxane-based …

I Skírnisdóttir, T Seidal - Oncology reports, 2012 - spandidos-publications.com
The objective of this study was to evaluate the prognostic effect of the apoptosis regulators
p53, bax and PUMA for recurrent disease and disease-free survival (DFS) in a series of 105 …

Survival and prognostic factors in early-stage epithelial ovarian carcinoma treated with taxane-based adjuvant chemotherapy

I Skírnisdóttir, B Sorbe - International Journal of Gynecologic Cancer, 2007 - ijgc.bmj.com
The present study was undertaken with the question about the outcome (recurrence-free
survival,[RFS]) after adjuvant chemotherapy with taxane and carboplatin in the early stages …